Overview

To Compare Positron Emission Tomography (PET) Measurements of Fibrillar Amyloid Burden

Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare PET measurements of fibrillar amyloid burden using [18F]AZD4694.
Phase:
Phase 2
Details
Lead Sponsor:
AstraZeneca